• All
  • Medtech
  • Therapeutics
Storm Therapeutics

Storm Therapeutics is a drug discovery company tackling oncology and other diseases through modulating RNA modifying enzymes.  The company is developing a unique platform to address these enzyme classes, including RNA methyltransferases.

Seroba contact: Bruno Montanari
Country: UK
Medlumics Portfolio

MedLumics is developing optically-guided, minimally-invasive instruments to improve the treatment of atrial fibrillation and other arrhythmias.

Seroba contact: Daniel O'Mahony
Country: Spain, Ireland
Atlantic Therapeutics Portfolio

Atlantic Therapeutics has developed a CE marked and FDA approved, neuromuscular electrical stimulation device, Innovo™, that treats urinary and faecal incontinence in a non-invasive manner.

Seroba contact: Daniel O'Mahony
Country: Ireland, UK, France, Germany, USA
Prexton Portfolio

Prexton is a clinical stage biotech that is developing novel treatments for the debilitating symptoms of late stage Parkinson’s disease. Prexton was acquired by Lundbeck in March 2018.

Seroba contact: Alan O'Connell
Country: Switzerland, The Netherlands
Novate Portfolio

Novate Medical has developed a novel inferior vena cava filter that converts from a filter to a stent, providing protection to patients at risk of pulmonary embolism.  Novate was sold to BTG in September 2018.

Seroba contact: Daniel O'Mahony
Country: UK, Ireland
Veryan Med Portfolio

Veryan developed innovative stent solutions to treat peripheral vascular disease.  Veryan received FDA pre-market approval in October 2018 and was acquired by Otsuka Medical in December 2018.

Seroba contact: Alan O'Connell
Country: UK, Ireland
Apica Cardiovascular Portfolio

Apica Cardiovascular developed novel access and closure devices for structural heart disease.  Apica was acquired by Thoratec in 2014.

Seroba contact: Daniel O'Mahony
Country: USA, Ireland
Pq Bypass Portfolio

PQ Bypass is developing a novel vascular stent graft, ancillary tools and an innovative procedure that treats long lesions in the peripheral vasculature.  PQ Bypass received CE Mark for its DETOUR™ device in 2017.

Seroba contact: Daniel O'Mahony
Country: USA, Ireland
Ario Pharma Portfolio

Ario Pharma is developing new therapeutics for the treatment of pain and type II diabetes with pharmaceutical partners.

Seroba contact: Alan O'Connell
Country: UK
Xention Portfolio

Xention is a cardiovascular biotech company. Its assets have now been partnered with or acquired by pharmaceutical companies.

Seroba contact: Alan O'Connell
Country: UK
Covagen Portfolio

Covagen was a biotech company that developed a novel platform technology for discovery and development of bispecific antibodies. The company was acquired by Janssen in 2014.

Seroba contact: Daniel O'Mahony
Country: Switzerland
Biosensia Portfolio

Biosensia merged with Kypha in 2018, a USA based in-vitro diagnostics company, to co-develop immune and inflammation assays on the Biosensia point-of-care RapiPlex platform.

Seroba contact: Jennifer McMahon
Country: Ireland
Crescent Diagnostics Portfolio

Crescent Diagnostics has developed Osentia®, a commercially available diagnostic test to identify an individual’s risk of developing osteoporosis.

Seroba contact: Alan O'Connell
Country: UK
Endotronix Portfolio

Endotronix is developing an implantable pulmonary artery pressure sensor and integrated patient management platform to provide comprehensive management tools for heart failure patients.

Seroba contact: Jennifer McMahon
Country: USA, Ireland
Fusion Portfolio

Fusion Pharmaceuticals is a clinical stage company focused on developing novel and targeted alpha therapeutics for the treatment of cancer.

Seroba contact: Alan O'Connell
Country: Canada, Ireland
Agi Therapeutics Portfolio

AGI Therapeutics was a specialty pharmaceutical company that was focused on the development and commercialisation of specialty drug products. The company did an IPO in 2006 and was subsequently acquired by Vidara Therapeutics.

Seroba contact: Peter Sandys
Country: Ireland
Alimentary Health Portfolio

Alimentary Health has developed microbiome-based healthcare and nutritional products for inflammatory and other conditions.

Seroba contact: Peter Sandys
Country: Ireland
Quanta Portfolio

Quanta Dialysis Technologies is developing advanced haemodialysis systems for dialysis patients which can be used in the home and in the clinic.

Seroba contact: Peter Sandys
Country: UK
Labcyte Portfolio

Labcyte is developing the revolutionary Echo acoustic liquid handling technology for applications in research and drug development – Seroba’s investee company Deerac Fluidics sold to Labcyte Inc. in 2008. Labcyte was acquired by Beckman Coulter in 2019.

Seroba contact: Peter Sandys
Country: USA, Ireland
Opsona Portfolio

Opsona is developing novel antibody therapeutics targeting toll-like immune receptors for the treatment of oncology and inflammatory conditions.

Seroba contact: Alan O'Connell
Country: Ireland
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19
Ireland

Scroll to Top